AMPEL BioSolutions Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 2

AMPEL BioSolutions General Information

Description

Operator of a precision health company intended to commercialize a development pipeline of tests that measure dynamic gene expression. The company is utilizing both data and clinical science to facilitate drug target identification and validation with optimal disease management for lupus or dermatology conditions such as psoriasis or eczema, enabling medical practitioners to cover all RNAs utilizing explainable predictive AI with therapeutic areas including autoimmunity, nephrology, cardiology, infectious disease, and lung cancer.

Contact Information

Formerly Known As
AMPEL LLC
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 250 West Main Street
  • Charlottesville, VA 22902
  • United States
+1 (240)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 250 West Main Street
  • Charlottesville, VA 22902
  • United States
+1 (240)

AMPEL BioSolutions Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AMPEL BioSolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 06-Jul-2023 $1.8M Completed Generating Revenue
5. Later Stage VC 13-Dec-2022 Completed Generating Revenue
4. Later Stage VC 31-Dec-2021 Completed Generating Revenue
3. Later Stage VC 15-Jun-2021 Completed Generating Revenue
2. Later Stage VC 17-Jan-2020 $12.5M $12.5M Completed Generating Revenue
1. Grant 01-Jan-2019 $3.1M Completed Startup
To view AMPEL BioSolutions’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AMPEL BioSolutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a precision health company intended to commercialize a development pipeline of tests that measure dynamic ge
Diagnostic Equipment
Charlottesville, VA
14 As of 2026

Waltham, MA
 

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AMPEL BioSolutions Competitors (9)

One of AMPEL BioSolutions’s 9 competitors is Scipher Medicine, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Scipher Medicine Venture Capital-Backed Waltham, MA
Guardant Health Formerly VC-backed Palo Alto, CA
Veracyte Formerly VC-backed South San Francisco, CA
Mindera Health Venture Capital-Backed Vista, CA
Exact Sciences Formerly VC-backed Madison, WI
You’re viewing 5 of 9 competitors. Get the full list »

AMPEL BioSolutions Patents

AMPEL BioSolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260226550-A1 Methods and systems for treatment determination and analysis Pending 06-Feb-2025
US-20260221227-A1 Systems and methods for molecular endotyping of rheumatoid arthritis Pending 04-Dec-2024
US-20260229358-A1 Methods and systems for determining gene sets for diagnosis and treatment of disease states Pending 03-Mar-2023
WO-2024186563-A1 Methods and systems for determining gene sets for diagnosis and treatment of disease states Inactive 03-Mar-2023
US-20260117297-A1 Longitudinal gene expression analysis of inflammatory skin diseases Pending 04-Jan-2023 C12Q1/6874
To view AMPEL BioSolutions’s complete patent history, request access »

AMPEL BioSolutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AMPEL BioSolutions Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Coddle Creek Capital Venture Capital Minority
United States Small Business Administration Government Minority
To view AMPEL BioSolutions’s complete investors history, request access »

AMPEL BioSolutions FAQs

  • When was AMPEL BioSolutions founded?

    AMPEL BioSolutions was founded in 2013.

  • Where is AMPEL BioSolutions headquartered?

    AMPEL BioSolutions is headquartered in Charlottesville, VA.

  • What is the size of AMPEL BioSolutions?

    AMPEL BioSolutions has 14 total employees.

  • What industry is AMPEL BioSolutions in?

    AMPEL BioSolutions’s primary industry is Diagnostic Equipment.

  • Is AMPEL BioSolutions a private or public company?

    AMPEL BioSolutions is a Private company.

  • What is AMPEL BioSolutions’s current revenue?

    The current revenue for AMPEL BioSolutions is .

  • How much funding has AMPEL BioSolutions raised over time?

    AMPEL BioSolutions has raised $37.9M.

  • Who are AMPEL BioSolutions’s investors?

    Coddle Creek Capital and United States Small Business Administration have invested in AMPEL BioSolutions.

  • Who are AMPEL BioSolutions’s competitors?

    Scipher Medicine, Guardant Health, Veracyte, Mindera Health, and Exact Sciences are some of the 9 competitors of AMPEL BioSolutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process